top
Search terms
Results 1 - 10 of 15 - ordered by :
Pages: 1 2
Heart

Fluid retention in these patients is not caused by heart failure and the exact mechanisms remain unclear. METHODS AND RESULTS--Haemodynamic variables, body fluid compartments, renal function, and ...

British Heart Journal, Research Article, I S Anand, Y Chandrashekhar, R Ferrari, P A Poole-Wilson, P C Harris

Date : 01/10/1993
Ehjcardiovascrec

[...]it became evident that natriuretic peptides may be used therapeutically. Because of their peptide character, they cannot be administered orally and, therefore, may be used for short-term ...

Cardiovascular Research, Review, Hans Peter Brunner-La Rocca, Wolfgang Kiowski, David Ramsay, Gabor Sütsch

Date : 15/08/2001 Item size : 523625 bytes
Ehjcardiovascrec

To investigate whether calcium antagonists or angiotensin-converting enzyme (ACE) inhibitors increase vascular nitric oxide activity, we assessed systemic and renal vascular sensitivity to nitric ...

Cardiovascular Research, Original Article, Lioe-Ting Dijkhorst-Oei, Jaap J. Beutler, Erik S.G. Stroes, Hein A. Koomans, Ton J. Rabelink

Date : 01/11/1998
Ehjournal

With dopexamine hydrochloride, there were dose-dependent increases from control in cardiac output and stroke volume, decreases in blood pressure, right and left atrial pressure, systemic vascular ...

European Heart Journal, BAUMANN, G., GUTTING, M., PFAFFEROTT, C., NINGEL, K., KLEIN, G.

Date : 01/05/1988 Item size : 106038 bytes
Ehjournal

With dopexamine hydrochloride, there were dose-dependent increases from control in cardiac output and stroke volume, decreases in blood pressure, right and left atrial pressure, systemic vascular ...

European Heart Journal, BAUMANN, G., GUTTING, M., PFAFFEROTT, C., NINGEL, K., KLEIN, G.

Date : 01/05/1988 Item size : 106338 bytes
Ehjournal

Many studies have addressed the prevalence of various cardiovascular risk factors in patients with AS, some of them suggesting possible therapeutic strategies to slow down disease progression.2 Among ...

European Heart Journal, Kaden, Jens J., Haghi, Dariusch

Date : 01/08/2008 Item size : 113868 bytes
Ehjournal

Dr Franz Messerli is nominated for the 2010 William Harvey Award of the American Society of Hypertension Franz H. Messerli, MD, FACC, FACP, originally from Switzerland and now Professor of Clinical ...

European Heart Journal

Date : 01/04/2010 Item size : 76100 bytes
Ehjournal

Abstract Aims Anabolic therapy with testosterone may be useful in the treatment of wasting associated with chronic heart failure but little is known about its cardiovascular actions. The aim of this ...

European Heart Journal, Pugh, Peter J., Jones, T. Hugh, Channer, Kevin S.

Date : 01/05/2003 Item size : 149908 bytes
Ehjcardiovascrec

[...]it became evident that natriuretic peptides may be used therapeutically. Because of their peptide character, they cannot be administered orally and, therefore, may be used for short-term ...

Cardiovascular Research, Peter Brunner-La Rocca, Hans, Kiowski, Wolfgang, Ramsay, David, Sütsch, Gabor

Date : 15/08/2001
Ehjcardiovascrec

To investigate whether calcium antagonists or angiotensin-converting enzyme (ACE) inhibitors increase vascular nitric oxide activity, we assessed systemic and renal vascular sensitivity to nitric ...

Cardiovascular Research, Dijkhorst-Oei, Lioe-Ting, Beutler, Jaap J., Stroes, Erik S.G., Koomans, Hein A., Rabelink, Ton J.

Date : 01/11/1998 Item size : 301528 bytes